Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
Savina Malancona, Monica Donghi, Marco Ferrara, Josè I Martin Hernando, Marco Pompei, Silvia Pesci, Jesus M Ontoria, Uwe Koch, Michael Rowley, Vincenzo Summa
Index: Bioorg. Med. Chem. 18 , 2836-48, (2010)
Full Text: HTML
Abstract
Chronic hepatitis C virus (HCV) infections are a significant medical problem worldwide. The NS5B Polymerase of HCV plays a central role in virus replication and is a prime target for the discovery of new treatment options. We recently disclosed 1H-benzo[de]isoquinoline-1,3(2H)-diones as allosteric inhibitors of NS5B Polymerase. Structural and SAR information guided us in the modification of the core structure leading to new templates with improved activity and toxicity/activity window.Copyright 2010 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-10-17
[Int. J. Food Microbiol. 189 , 98-105, (2014)]
2014-01-01
[PLoS ONE 9(6) , e99421, (2014)]
2014-04-01
[Pharmacogn. Mag. 10(Suppl 2) , S383-91, (2014)]
2014-07-18
[ACS Chem. Biol. 9(7) , 1595-602, (2014)]
2014-09-01
[Appl. Environ. Microbiol. 80(18) , 5583-92, (2014)]